Showing results (241-250 of 3,194) with videos related to
Sort By:
Pageof 320
Chemical Communications (Cambridge, England)|March 3, 2005
pi-Indenyl tin(II) and lead(II) compoundsJamie N Jones, Alan H CowleyDiagnostic Microbiology and Infectious Disease|January 1, 1994
Antimicrobial activity of a new antipseudomonal dual-action drug, Ro 25-0534R N Jones, M L SanchezEuropean Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 1994
In vitro antimicrobial activity of cefpirome against ceftazidime-resistant isolates from two multicenter studiesH S Sader, R N JonesPsychopharmacology|March 1, 1994
Influence of naloxone upon motor activity induced by psychomotor stimulant drugsD N Jones, S G HoltzmanChemotherapy|January 1, 1995
Canadian ofloxacin susceptibility study: a comparative study from 18 medical centers. Canadian Ofloxacin Study GroupD J Hoban, R N JonesJournal of the American College of Nutrition|January 1, 1983
Nutritional assessment and preliminary report on early support of the trauma patientE E Moore, T N JonesJournal of Clinical Microbiology|January 1, 1995
Susceptibility to levofloxacin predicted from in vitro susceptibility testing results obtained with ciprofloxacin and with ofloxacinM G Cormican, R N JonesAntimicrobial Agents and Chemotherapy|June 1, 1984
Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid after in vitro selection of resistant populationsA L Barry, R N JonesDiagnostic Microbiology and Infectious Disease|May 1, 1997
Microbiologic and pharmacodynamic principals applied to the antimicrobial susceptibility testing of ampicillin/sulbactam: analysis of the correlations between in vitro test results and clinical responseR N Jones, M N DudleyDiagnostic Microbiology and Infectious Disease|May 1, 1989
In vitro evaluation of ramoplanin (A16686 or MDL62198). A new depsipeptide complex for potential topical useR N Jones, A L BarryPageof 320